Round table: arguments in supporting abbreviated or biparametric MRI of the prostate protocol

Michele Scialpi1, Eugenio Martorana2, Pietro Scialpi3

  • 1Section of Diagnostic Imaging, Department of Surgical and Biomedical Sciences, Santa Maria della Misericordia Hospital, University of Perugia, S. Andrea delle Fratte, 06156, Perugia, Italy. michelescialpi1@gmail.com.

Insights

The Prostate Imaging Reporting and Data System (PI-RADS) v2.1 has limitations. This study supports abbreviated or biparametric prostate MRI protocols for prostate cancer detection and management.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • The Prostate Imaging Reporting and Data System (PI-RADS) version 2.1 aims to standardize multiparametric MRI (mpMRI) for prostate cancer.
  • Current PI-RADS v2.1 guidelines present limitations, including undefined roles for dynamic contrast-enhanced sequences and unclear management strategies for PI-RADS 3 lesions.

Purpose of the Study:

  • To address the limitations of PI-RADS v2.1.
  • To present criteria supporting the use of abbreviated or biparametric prostate MRI protocols for prostate cancer detection and management.

Main Methods:

  • Review and analysis of existing PI-RADS v2.1 guidelines.
  • Development of criteria and arguments for abbreviated/biparametric MRI protocols.

Main Results:

  • PI-RADS v2.1 has limitations in defining the role of dynamic contrast-enhanced sequences.
  • Management of PI-RADS 3 lesions remains ambiguous, requiring subjective interpretation.
  • Abbreviated or biparametric MRI protocols offer a viable alternative for prostate cancer assessment.

Conclusions:

  • The current PI-RADS v2.1 update has significant limitations impacting clinical practice.
  • Abbreviated or biparametric prostate MRI protocols show promise for improving the detection and management of prostate cancer.